GERSTEL Opioids/Cocaine Solution

Significance of the topic

The automated quantification of opioids, cocaine and metabolites in blood serum is crucial for forensic toxicology, clinical research and quality control in laboratories. Reliable detection at low concentration levels aids in compliance monitoring and helps in understanding pharmacokinetics and drug metabolism.

Goals and overview of the solution

This solution aims to fully automate sample preparation and GC/MS analysis of 0.6 mL serum samples for eight target analytes. It integrates protein precipitation, internal standard addition, solid phase extraction (SPE), evaporation, derivatization and injection into a cooled injection system, streamlining workflows and increasing sample throughput.

Methodology and instrumentation

• Manual protein precipitation followed by addition of isotopically labeled internal standards
• Automated SPE on 1 mL cartridges to extract analytes
• Solvent evaporation of SPE eluate using a multi position mVAP station
• Chemical derivatization to improve GC/MS detection
• Automated injection via GERSTEL Cooled Injection System (CIS)
• GC/MS analysis on Agilent 7890 GC coupled to 5977 MSD, controlled by MassHunter software

System components

• MPS Dual Head sampler with gas supply in both towers
• SPE module with deactivated heating and shaking functions
• Multi Position Evaporation Station (mVAP) with one active position and condenser pump
• Solvent Filling Stations, trays for SPE cartridges, sample vials and eluate vials
• Standard wash station and syringes for sample preparation and injection

Main performance and discussion

The method supports calibration ranges from low single digit to 1500 ng/mL for eight analytes and can process up to 97 samples in one automated sequence, achieving around 29 analyses per day. Data demonstrate robust extraction efficiency, consistent derivatization and stable GC/MS signals, reducing variability associated with manual handling.

Benefits and practical applications

• Enhanced laboratory throughput and standardized sample handling
• Improved data quality and reproducibility through full automation
• Applicability in forensic, clinical and QA/QC environments for drug screening and monitoring

Future trends and possibilities

Future developments may include coupling with LC/MS for expanded analyte coverage, miniaturized SPE formats to cut solvent use, and integration of AI-driven data analysis. Extension to therapeutic drug monitoring and new psychoactive substances is foreseen.

Conclusion

The GERSTEL Opioids/Cocaine Solution offers a comprehensive, high-throughput workflow for serum analysis, combining robust SPE, evaporation, derivatization and GC/MS quantification. By minimizing hands-on steps and ensuring reproducible results, it supports laboratories in achieving reliable drug analysis outcomes.

Reference

No external references were provided in the source document.